LG 100754

Names

[ Name ]:
LG 100754

[Synonym ]:
cd 3159

Biological Activity

[Description]:

LG100754 (UVI 2112) is a RXR dimers modulater. LG100754 acts as a RXR:RXR homodimer antagonist, but functions as a agonist towards RXR:PPARα and RXR:PPARγ heterodimers. LG100754 is an insulin sensitizer that functions through RXR[1].

[Related Catalog]:

Research Areas >> Metabolic Disease

Signaling Pathways >> Metabolic Enzyme/Protease >> RAR/RXR

[Target]

PPARα

PPARγ

[In Vitro]

LG100754 is a selective activator of endogenous RXR heterodimers[1]. LG100754 can also improve TNFα-mediated insulin resistance in mature adipocytes[1]. LG100754 acts as a bona fide activator of endogenous RXR:PPARγ heterodimers and regulator of insulin-dependent signaling pathways[1].

[In Vivo]

LG100754 (100 mg/kg) completely blocks the increase in glucose levels, suggesting that LG100754 can improve insulin resistance in vivo[1].

[References]

[1]. Cesario RM, et al. The rexinoid LG100754 is a novel RXR:PPARgamma agonist and decreases glucose levels in vivo. Mol Endocrinol. 2001 Aug;15(8):1360-9.

Chemical & Physical Properties

[ Density]:
1.003g/cm3

[ Boiling Point ]:
549.4ºC at 760 mmHg

[ Molecular Formula ]:
C₂₆H₃₆O₃

[ Molecular Weight ]:
396.56200

[ Flash Point ]:
178.5ºC

[ Exact Mass ]:
396.26600

[ PSA ]:
46.53000

[ LogP ]:
6.81480

[ Vapour Pressure ]:
6.63E-13mmHg at 25°C

[ Index of Refraction ]:
1.526

Safety Information

[ RIDADR ]:
NONH for all modes of transport

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.